"people with overweight" Is that a new thing? Bizarrely, I first saw this usage only this morning in the title of this article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00355-1/fulltext
Scientific Reports, despite being published by Nature [Publishing Group], is not a quality journal, but this fact isn't really appreciated outside of academia. They accept a large percentage of submitted papers, very often publish trash, and the journal has been implicated in numerous scientific...
I listened to her audiobook 'It's All In Your Head' last year. Truly awful, and read by someone with the most snooty, patronising tone, which really fit the content. I could not finish it. More here: https://me-pedia.org/wiki/Suzanne_O'Sullivan
It's all very bizzare. LDN seems to have a cult following, much like ivermectin has. I think the LDN Trust puts out questionable literature to entice patients.
I developed Raynauds in my late teens or early 20s. I'm not sure I even have it any more as I don't go outside much, especially when it's cold. It never bothered me too much, but it seems to be indicative of some sort of underlying dysfunction that's likely auto-immune in nature.
https://www.bbc.co.uk/news/articles/cx2gky52p5qo
"About 15 years ago, Tim Holt-Wilson noticed a "gradual degeneration" in the warmth of his fingers.
The 66-year-old, who lives near Eye, in Suffolk, had already been diagnosed with the autoimmune condition Scleroderma - which caused stiff skin...
I didn't. At the time I was part of the CMRC PAG and some of these thoughts made it back to BACME members via feedback we were asked to give on a talk Vikki McKeever and Peter Gladwell gave. Also, Sue Pemberton, who had by then left BACME, messaged me on the subject of my blog, so it made it to...
They are calling it 'International Conference Week' now as there are several events/conferences running consecutively, as is usual for IIMER. More details here: https://www.investinme.org/meconferenceweek2025.shtml
Thanks for posting this Andy. These corrections have been made after I contacted the journal editors about the issues as well as Reviewer 1's 'I clearly didn't even bother to read the paper' review. BMJ tells me that "[they] have verified that the standard of peer review met the journal's...
I think we can safely conclude that it seems they don't want patients to know which drug this is, but they are probably underestimating our ability to figure it out (I think Amifampridine is a good guess).
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.